TrialAIDS (London, England)2012

Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.

Grace A McComsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.